KLK3 and benign prostatic hyperplasia: Notably, one study reported that PSAD has limitations in very large prostates and found no direct correlation between PSA level and benign prostatic hyperplasia (BPH) tissue volume, implying that PSA (and thus PSAD) does not simply scale with prostate size [17].